Skip to main content

Next Generation Sequencing (NGS) Market, Global Forecast by End User, Type of Test, Disease, Informatics, Reimbursement, Company Analysis, Platform, Consumable

Next Generation Sequencing (NGS) Market, Global Forecast by End User, Type of Test, Disease, Informatics, Reimbursement, Company Analysis, Platform, Consumable
Next Generation Sequencing Market is expected to surpass US$ 30 Billion by the end of year 2025 with double digit CAGR during 2019-2025
Renub Research report titled “Next Generation Sequencing Market, Global NGS Forecast by End User, Type of Test, Disease, Informatics (NGS Informatics Services, Primary and Secondary Data Analysis Tools, Storage, Computing, Biological Interpretation and Reporting Tools, LIMS Laboratory Information Management System), Reimbursement, Company Analysis (Illumina, Thermo Fisher Scientific, Platform, Consumable" provides a complete analysis of global Next Generation Sequencing (NGS) Market.

Next Generation Sequencing (NGS) is a recent technology in which billions of DNA strands can be sequenced through massive parallel sequencing. The Next-Generation Sequencing has revolutionized the biological study, with its ultra-high throughput, speed and scalability; it has enabled professionals to perform a wide variety of applications and study biological systems at a level which have never been possible before. The NGS technology is also referred as High Throughput Sequencing. This technique minimizes the necessity for fragment-cloning methods used in Sanger sequencing of genomes. The NGS offers rapid speed, low cost, high accuracy, and accurate result even with the low sample input. The use of NGS in clinical diagnostic is one of the major factors for future growth of NGS. Next Generation Sequencing Market is expected to surpass US$ 30 Billion by the end of year 2025 with double digit CAGR during 2019-2025.  

Next Generation Sequencing has the possibility to accelerate the early finding of the ailments and the recognition of pharmacogenetics markers to customize its treatments. Today, in the field of medical science, a lot of various technological advancements are going at a rapid pace and that has led to the development of a specific medicine. As a result, the development of custom made medicine has opened an enormous opportunities for the application of next generation sequencing, which could help NGS market to grow significantly over the forecast period. 

 

Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=next-generation-sequencing-market-p.php

 

In addition; some of the major factors responsible for the growth of Next Generation Sequencing are increasing NGS application in biological study due to its efficient advantage over traditional technologies and growing demand from the drug discovery industry. Additionally, ethical concerns associated with the whole-genome sequencing along with the lack of awareness among people are some of the factors which are expected to restrain the market growth during the forecast period. 

 

Oncology Test Market is largest among Clinical Next Generation Sequencing Market 

In this report, we have defined next generation sequencing test market by clinical application.  NGS test market is categorized into 6 parts; NGS Test Market by Reproductive Health, NGS Test Market by Rare Disease, NGS Test Market by Oncology, NGS Test Market by Metabolic, NGS Test Market by Cardiavascular and Others NGS Test Market.

 

 

Target Re-Sequencing and Whole Exome sequencing is dominating the Clinical Next Generation Sequencing Market
 
In this report, we have done complete assessment of different next generation sequencing technique. Here, we have categorized clinical next generation sequencing market by type of test into six parts; Targeted Re-sequencing (TPS/WES), Transcriptome (RNA- Sequencing), Whole Genome Sequencing, ChIP- Sequencing, De Novo Sequencing (Novel Organisms) and Methyl-Sequencing.


Next Generation Sequencing Market Trends by Platform

There are several platforms designed for next generation sequencing for the period of time by top key players. In this report, we have shown the next generation sequencing market by platform. 

 

Client can Purchase this Report in Sections from below link:

Access full Research: https://www.renub.com/next-generation-sequencing-market-p.php

 

Next Generation Sequencing Market Insight by Consumables

In this report, we have done comprehensive analysis on NGS market by consumables. There are various kinds of consumable used in next generation sequencing like sample, library preparation reagents, kits, automation devices etc.

 

Next Generation Sequencing Informatics Market 

NGS Informatics is one of the key growth factors that propel overall NGS market to expand at rapid pace. In this report, next generation sequencing informatics market is divided into 6 parts; NGS Informatics Services, Primary and Secondary Data Analysis Tools, Storage, Computing, Biological Interpretation and Reporting Tools and Laboratory Information Management System. 
 

Company Analysis

All the companies has been analyzed from following points Overview, Recent Developments & Strategy

  • Illumina
  • Thermo Fisher Scientific
  • Pacific Biosciences
  • Oxford Nanopore Technologies
  • Roche

 

If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team at info@renub.com  

 

Browse Related Report :

United States Dental Market

Saudi Arabia In-Vitro Diagnostic Market

 

Contact Us

Renub Research

Phone:+1-678-302-0700

Email: info@renub.com

 

Key Topics Covered :

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

    4.1 Growth Driver
    4.2 Challenges

5. Global Next Generation Sequencing (NGS) Market

6. Market Share – Global Next Generation Sequencing (NGS)

    6.1 By End-User
    6.2 By Type of Test
    6.3 By Disease
    6.4 By NGS Informatics Type

7. End-User – Global Next Generation Sequencing Market

    7.1 Academic Research
    7.2 Healthcare
    7.3 Biotech/Pharma
    7.4 Government
    7.5 Others

8. Type of Test – Global Clinical Next Generation Sequencing Market

    8.1 Targeted Re-sequencing (TPS/WES)
    8.2 RNA-Sequencing
    8.3 Whole Genome Sequencing
    8.4 ChIP-Sequencing
    8.5 De Novo Sequencing
    8.6 Methyl-Sequencing

9. Disease – Global Next Generation Sequencing Test Market

    9.1 Reproductive Health
    9.2 Rare Disease Diagnostics
    9.3 Oncology (Cancer)
    9.4 Metabolic Immune (Diagnostic)
    9.5 Cardiovascular
    9.6 Others

10. Platform – Global Next Generation Sequencing Market

11. Consumable – Global Next Generation Sequencing Market

12. Informatics – Global Next Generation Sequencing Market

    12.1 NGS Informatics Services
    12.2 Primary and Secondary Data Analysis Tools
    12.3 Storage
    12.4 Computing
    12.5 Biological Interpretation and Reporting Tools
    12.6 LIMS (Laboratory Information Management System)

13. Reimbursement

14. Company Analysis

    14.1 Illumina
    14.2 Thermo Fisher Scientific
    14.3 Pacific Biosciences
    14.4 Oxford Nanopore Technologies
    14.5 Roche

About Us

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

 

Media Contact
Company Name: Renub Research
Contact Person: Rajat Gupta
Email: Send Email
Phone: +1-678-302-0700
Address:225 Kristie Ln
City: Roswell
State: Georgia
Country: United States
Website: www.renub.com/life-science-1-c.php



Source: www.abnewswire.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.